Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1978-06-16
1979-12-25
Schafer, Richard E.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
424 12, 23230B, G01N 3316, A61K 3900
Patent
active
041805569
ABSTRACT:
An improvement in a method for the separation of carcinoembryonic antigen (CEA) from a plasma sample preparatory to conducting an assay for said antigen is disclosed.
REFERENCES:
patent: 3663684 (1972-05-01), Freedman et al.
patent: 3867363 (1975-02-01), Hansen
Kolthoff et al., Textbook of Quantitative Inorganic Analyses, 3rd Ed. MacMillan Co., N.Y. (1952), pp. 398-400.
Ashman et al., Clinica Animia Acta, vol. 74 (1977), pp. 77-84.
Tatarinov et al., Chem. Abstracts, vol. 82, No. 19 (1975), Abstract #123040p.
Duraiswami et al., Chem. Abstracts, vol. 84, No. 25, (1976), Abstract #178102g.
Kim Yung D.
Schenck Jay R.
Tomita Joseph T.
Abbott Laboratories
Nucker Christine M.
Schafer Richard E.
Willmann Neal O.
LandOfFree
Pretreatment method for carcinoembryonic antigen assay does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pretreatment method for carcinoembryonic antigen assay, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pretreatment method for carcinoembryonic antigen assay will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2070384